Human Longevity Inc. [2013] a pioneer and leader in precision health and parent company to Health NucleusTM and Longevity and Performance Impact Venture Fund (LPIF), has become a clearing house for promising longevity and performance focused technologies. With the longevity economy expected to reach twenty six (26) trillion dollars by 2017 LPIF is seeking to raise $50M to establish synergistic ecosystem of high-impact translational research, diagnostic and therapeutic companies. 

Contact us for investor relations information